Dr. Kelly Credille has focused her career on comparative pathology and translational medicine to improve human and animal health. In her current role in Diagnostic and Experimental Pathology within Lilly Research Labs, she develops biomarkers by correlating gene and protein expression with morphology in order to match patients to medicines. As a consequence she has a strong interest in image analysis and the application of deep learning tools to morphology and pathology. To this end, she believes the future of anatomic pathology is its transition from a descriptive to a quantitative discipline.

Kelly also supported safety assessment of new medicines in Toxicology for several years.

Prior to Lilly, in academia, she achieved internationally recognized expertise in diagnostic and research comparative dermatopathology. Kelly earned her DVM and PhD at Michigan State University and trained in anatomic pathology at Cornell University, receiving her certification from the American College of Veterinary Pathologists.